Antitussive and immunomodulating activities of instant coffee arabinogalactan-protein

International Journal of Biological Macromolecules

Volumn 49, Issue 4, 2011, Pages 493-497

  Nosalova G ^a   Prisenznakova L ^a   Paulovicova E ^b   Capek, P ^b   Matulova M ^b   Navarini, L ^c   Liverani, F Suggi ^c  

^a University Hospital in Martin   (Slovakia)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

^c R and D   (Italy)

Author keywords

Antitussive activity; Arabinogalactan protein; Coffea arabica; Immunomodulating activity; Instant coffee

Indexed keywords

ANTITUSSIVE AGENT; ARABINOGALACTAN PROTEIN COMPLEX; ARABINOSE; BETA D GLUCAN; CODEINE PHOSPHATE; CONCANAVALIN A; GALACTOSE; GAMMA INTERFERON; IMMUNOMODULATING AGENT; INTERLEUKIN 2; PLANT MEDICINAL PRODUCT; POLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTITUSSIVE ACTIVITY; ARTICLE; BREATHING MUSCLE; CELLULAR IMMUNITY; COFFEE; CONCENTRATION RESPONSE; CONTROLLED STUDY; COUGHING; CYTOKINE RELEASE; DOSE RESPONSE; DRUG ACTIVITY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG ISOLATION; EX VIVO STUDY; FEMALE; GUINEA PIG; IMMUNE SYSTEM; IMMUNOASSAY; IMMUNOCOMPETENT CELL; IMMUNOMODULATING ACTIVITY; IN VIVO STUDY; MALE; MEDIATOR RELEASE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN INDUCTION; SPLEEN CELL; TH1 CELL;

COFFEA ARABICA;

EID: 80052293625     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2011.06.004     Document Type: Article

References (36)

1. Higdon J.V., Frei B. Coffee and health: a review of recent human research. Crit. Rev. Sci. Nutr. 2006, 46:101-123.
2. Nawrot P., Jordan S., Eastwood J., Rotstein J., Hugengoholtz A., Feeley M. Effect of caffeine in human health. Food Addit. Contam. 2003, 20:1-30.
3. Salazar-Martínez E., Willet W.C., Ascherio A., Manson J.E., Leitzman M.F., Stampfer M.J., Hu F.B. Coffee consumption and risk for type 2 diabetes mellitus. Ann. Intern. Med. 2004, 140:1-8.
4. Bara A.I., Barley E.A. Caffeine for asthma. Cochrane Database Syst. Rev. 2001, 4. CD001112.
5. Urgent R., Weg G., Kosmeijer-Schuil T.G., Bovenkamp P., Hovenier R., Katan M.B. Levels of cholesterol elevating diterpenes cafestol and kahweol in various coffeebrews. J. Agric. Food Chem. 1995, 43:2167-2172.
6. Sharp D.S., Everhart J.E., Benowitz N.L. Coffee, alcohol and the liver. Ann. Epidemiol. 1999, 9:391-393.
7. Ranheim T., Hlavorsen B. Coffee consumption and human health-beneficial or detrimnetal?-mechanisms for effects of coffee consumption on different risk factors for cardiovascular disease and type 2 diabetes mellitus. Mol. Nutr. Food Res. 2005, 49:274-284.
8. Cornelis M.C., El-Sohemy A. Coffee, caffeine, and coronary heart disease. Curr. Opin. Clin. Nutr. Metab. Care 2007, 10:745-751.
9. Spiller M.A. Caffeine 1998, 97-161. CNR Press, Boca Raton, FL. G.S. Spiller (Ed.).
10. Bradbury A.G.W. Coffee Recent Developments 2001, 1-17. Blackwell Science, Oxford. R.J. Clarke, O.G. Vitzthum (Eds.).
11. Redgwell R.J., Curti D., Fischer M., Nicolas P., Fay L.B. Coffee bean arabinogalactans: acidic polymers covalently linked to protein. Carbohydr. Res. 2002, 337:239-253.
12. Nunes F.M., Reis A., Silva A.M.S., Rosario M., Domingues M., Coimbra M.A. Rhamnoarabinosyl and rhamnoarabinoarabinosyl side chains as structural features of coffee arabinogalactan. Phytochemistry 2008, 69:1573-1585.
13. Wolfrom M.L., Anderson L.E. Polysaccharides from instant coffee powder. J. Agric. Food Chem. 1967, 15:685-687.
14. Capek P., Matulová M., Navarini L., Suggi-Liverani F. A comparative study of arabinogalactan-protein isolates from instant coffee powder of Coffea arabica beans. J. Food Nutr. Res. 2009, 48:80-86.
15. Capek P., Matulová M., Navarini L., Suggi-Liverani F. Structural features of an arabinogalactan-protein isolated from instant coffee powder of Coffea arabica beans. Carbohydr. Polym. 2010, 80:180-185.
16. Matulová M., Capek P., Kaneko S., Navarini L., Liverani F.S. Structure of arabinogalactan oligosaccharides derived from arabinogalactan-protein of Coffea arabica instant coffee powder. Carbohydr. Res. 2011, 346:1029-1036.
17. Wills R.B.H., Bone K., Morgan M. Herbal products: active constituents, modes of action and quality control. Nutr. Res. Rev. 2000, 13:47-77.
18. Paulsen B.S. Biologically active polysaccharides as possible lead compounds. Phytochem. Rev. 2002, 1:379-387.
19. Lee Ch.J., Huo Y.-S., Lee L.H., Lu Ch-H., Koizumi K. Immunomodulating fungal and plant polysaccharides, biochemistry, immunologic activity and clinical application. J. Trad. Med. 2004, 21:67-80.
20. Pavlaczyk I., Czerchawski L., Kańska J., Bijak J., Capek P., Pliszczak-Król A., Gancarz R. An acidic glycoconjugate from Lythrum salicaria L. with controversial effects on hemostasis. J. Ethnopharmacol. 2010, 131:63-69.
21. Nosáľová G., Capek P., Šutovská M., Fraňová S., Matulová M. Floriculture, Ornamental and Plant Biotechnology 2006, vol. IV:472-481. GSB, Middlesex, UK.
22. Paulsen B.S. Plant polysaccharides with immunostimulatory activities. Curr. Org. Chem. 2001, 5:939-950.
23. Kraus J., Franz G. Immunomodulating effects of polysaccharides from medicinal plants. Adv. Exp. Med. Biol. 1992, 319:299-308.
24. Shapira J. Identification of sugars as their trifluoroacetylpolyol derivatives. Nature 1969, 222:792-793.
25. Šutovská M., Nosáľová G., Šutovský J., Fraňová S., Prisenžňáková L., Capek P. Possible mechanisms of dose-dependent cough suppressive effect of Althaea officinalis rhamnogalacturonan in guinea pigs test system. Int. J. Biol. Macromol. 2009, 45:27-32.
26. Pennock B.E., Cox C.P., Rogers R.M., Cain W.A., Wells J.H. A noninvasive technique for measurement of changes in specific airway resistance. J. Appl. Physiol. 1979, 46:399-406.
27. Bánovčin P., Zibolen M., Nosáľ S. Diagnostic and Therapy in Pediatric Practice 1999, JMF, Martin, UK, pp. 125.
28. Šutovská M., Fraňová S., Prisenžňáková L., Nosáľová G., Togola A., Diallo D., Paulsen B.S., Capek P. Antitussive activity of polysaccharides isolated from the Malian medicinal plants. Int. J. Biol. Macromol. 2009, 44:236-239.
29. Chattopadhyay N., Nosáľová G., Saha S., Bandyopadhyay S.S., Flešková D., Ray B. Structural features and antitussive activity of water extracted polysaccharide from Adhatoda vasica. Carbohydr. Polym. 2011, 83:1970-1974.
30. Saha S., Nosáľová G., Ghosh D., Flešková D., Capek P., Ray B. Structural features and in vivo antitussive activity of the water extracted polymer from Glycyrrhiza glabra. Int. J. Biol. Macromol. 2011, 48:634-638.
31. Locksley R.M., Killeen N., Lenardo M.J. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001, 104:487-501.
32. Old L.J. Tumor necrosis factor (TNF). Science 1985, 230:630-632.
33. Belardi F. Role of interferons and other cytokines in the regulation of the immune response. APMIS 1995, 103:161-179.
34. Trinchieri G., Perussia B. Immune interferon: a pleiotropic lymphokine with multiple effects. Immunol. Today 1985, 6:131-136.
35. Sechler J.M., Malech H.L., White C.J., Gallin J.I. Recombinant human interferon-γ reconstitutes defective phagocyte function in patients with chronic granulomatous disease of childhood. Proc. Natl. Acad. Sci. U.S.A. 1988, 85:4874-4878.
36. Hatakeyama M., Taniguchi T. Interleukin-2 in Peptide Growth Factors and Their Receptor I 1990, 523-540. Springer-Verlag, New York. M.B. Sporn, A.B. Roberts (Eds.).